FDA Cooperative Agreement to Research Ways to Reduce Nitrosamine Impurities in Drugs (U01)
The FDA (CDER/Office of New Drugs) is funding cooperative research to identify and evaluate approaches to address nitrosamine impurities in human medicines. The goal is to develop translational, practical methods that improve drug safety and reduce public health risks without limiting access to important therapies. The awardee will also plan how these research practices can continue in academi…
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers